Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The peroxisome proliferator-activated receptor alpha L162V mutation is associated with reduced adiposity.

Obesity research - 1 Jul 2003

Bossé Yohan, Després Jean-Pierre, Bouchard Claude, Pérusse Louis, Vohl Marie-Claude

Abstract excerpt

OBJECTIVE: To determine the contribution of the peroxisome proliferator-activated receptor alpha (PPARalpha) L162V mutation to the variation of several indexes of body fatness obtained from healthy adults who participated in the Quebec Family Study. RESEARCH METHODS AND PROCEDURES: The PPARalpha L162V mutation was determined by a mismatch polymerase chain reaction method. Adiposity phenotypes were obtained by...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Abdomen
Share to Adipose Tissue
Share to Body Composition

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Body Constitution

Share to Body Mass Index

Share to Body Weight

Share to Receptors, Cytoplasmic and Nuclear

Share to Tomography, X-Ray Computed

Source

Identifiers

PMID: 12855749
DOI: 10.1038/oby.2003.112

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The peroxisome proliferator-activated receptor alpha L162V mutation is associated with reduced adiposity.PMID 12855749Read ↗

Association between the PPARalpha-L162V polymorphism and components of the metabolic syndrome.Semantic proximity Read ↗

Molecular scanning of the human PPARa gene: association of the L162v mutation with hyperapobetalipoproteinemia.Semantic proximity Read ↗

Association Between the PPARA L162V Polymorphism and Plasma Lipid LevelsSemantic proximity Read ↗

A polymorphism, L162V, in the peroxisome proliferator-activated receptor α (PPAR α) gene is associated with lower body mass index in patients with non-insulin-dependent diabetes mellitusSemantic proximity Read ↗

The peroxisome proliferator-activated receptor alpha Leu162Val polymorphism influences the metabolic response to a dietary intervention altering fatty acid proportions in healthy men.Semantic proximity Read ↗

Impact of polymorphisms of the human beta2-adrenoceptor gene on obesity in a French population.Semantic proximity Read ↗

PPARalpha L162V underlies variation in serum triglycerides and subcutaneous fat volume in young males.Semantic proximity Read ↗

PPAR-alpha L162V and PGC-1 G482S gene polymorphisms, but not PPAR-gamma P12A, are associated with alcohol consumption in a Spanish Mediterranean population.Semantic proximity Read ↗

The L162V polymorphism of the peroxisome proliferator activated receptor alpha gene (PPARA) is not associated with type 2 diabetes, BMI or body fat composition.Semantic proximity Read ↗

Combined effects of PPARgamma2 P12A and PPARalpha L162V polymorphisms on glucose and insulin homeostasis: the Québec Family Study.Semantic proximity Read ↗

Effects of beta2-adrenergic receptor gene variants on adiposity: the HERITAGE Family Study.Semantic proximity Read ↗

Association of peroxisome proliferator-activated receptor delta +294T/C with body mass index and interaction with peroxisome proliferator-activated receptor alpha L162V.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.